IL10 and colitis: The findings that butyrate-treated Prdm1−/− Th1 cells produced lower levels of IL-10 and were not able to control colitis as effectively as butyrate-treated WT Th1 cells indicate the importance of Blimp-1-mediated SCFA induction of IL-10 production in controlling colitis development.